09-06-2021 02:00 PM | Source: Reuters
India's Hetero wins emergency use nod to make Roche's COVID-19 drug
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
BENGALURU - Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
(Reporting by Shivani Singh in Bengaluru; Editing by Devika Syamnath)
Latest News
RBI tweaks rules to cut risk banks face in exposure ...
Raymond posts 18 per cent jump in Q4 net profit at R...
Daily Market Commentary : Nifty after marking a new ...
Priyanka says being part of `Womb` has been nothing ...
Buy Zinc Above 259 SL. BELOW 256 TGT 263/264 - Axis...
From Alaya F to Daler Mehndi & Sudhanshu Pandey, cel...
T20 World Cup: `Four spinners... Rinku Singh should ...
Shubhankar Sharma, Gaganjeet Bhullar seek golfing br...
BIPF`s 11 th Shambhavi Puraskar honours efforts for ...
Mahindra & Mahindra received record 674 patents in FY24
